Taken together, these results indicate that serum/xeno-free culture conditions induced enhanced IDO production by human WJ-MSCs, which led to efficient anti-inflammatory modulation of immune cells, and the immunosuppressive effects of XF-MSCs are sufficient for the significant attenuation of colitis. Here, IDO1 is linked to colitis.